SEC Form 4 · accession 0000921895-16-005107
Actinium Pharmaceuticals, Inc. · ATNM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Jul 5, 2016
Accepted (ET)
Jul 7, 2016 · 4:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 5, 2016 | S | 6,000 | $1.82 | D | 5,001,886 | D | |
| Common Stock | Jul 5, 2016 | S | 4,340 | $1.83 | D | 4,997,546 | D | |
| Common Stock | Jul 6, 2016 | S | 10,500 | $1.80 | D | 4,987,046 | D |
Table II — derivative securities
No Table II lines on this filing.